Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATpase activities by interaction with dietary flavonoids

Molecular Pharmacology

Volumn 59, Issue 5, 2001, Pages 1171-1180

  Leslie, Elaine M ^a   Mao, Qingcheng ^a   Oleschuk, Curtis J ^a   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; APIGENIN; AURANTIIN; BIOFLAVONOID; ESTRADIOL; GENISTIN; GLUTATHIONE; KAEMPFEROL; LEUKOTRIENE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MYRICETIN; NARINGENIN; QUERCETIN; UNCLASSIFIED DRUG; VANADIC ACID;

ARTICLE; DRUG INHIBITION; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPOPHILICITY; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

EID: 0035033774     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.5.1171     Document Type: Article

References (48)

1. Genistein, a specific inhibitor of tyrosine-specific protein kinases
2. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions
3. Membrane topology and glycosylation of the human multidrug resistance-associated protein
4. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells
5. ATPase activity of purified multidrug resistance-associated protein
6. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
7. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
8. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein
9. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: A structure-activity relationship study
10. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1
11. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
12. 2-terminus
13. Structural, mechanistic and clinical aspects of MRP1
14. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies
15. Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP. Localization of their epitopes to the nucleotide-binding domains of the protein
16. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein
17. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
18. Potent interaction of flavopiridal with MRP1
19. The effect of glutathione on the ATPase activity of MRP1 in its natural membranes
20. ATP hydrolysis by a CFTR domain: Pharmacology and effects of G551D mutation
21. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein
22. Mutation of a single conserved tryptophan in multidrug resistance protein I (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport
23. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
24. Intake of flavonoids and lung cancer
25. 4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport
26. Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: Evidence for co-transport with reduced glutathione
27. Verapamil stimulates glutathione transport by the multidrug resistance protein 1 (MRP1)
28. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
29. Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phopholipid vesicles
30. ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells
31. Non-equivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1
32. In vitro glucuronidation of kaempferol and quercetin by human UGT-1A9
33. Correlation between the affinity of flavonoids binding to the cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin
34. Flavonoids activate wild-type p53
35. Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1
36. Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein
37. Antiestrogens and steroid hormones: Substrates of the human P-glycoprotein
38. New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models
39. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1
40. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein
41. The P-glycoprotein efflux pump: How does it transport drugs?
42. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
43. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP)
44. Efflux of dietary flavonoid quercetin 4′-O-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2
45. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2
46. Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects
47. Dietary quercetin glycosides: Antioxidant activity and induction of the anticarcinogenic phase II marker enzyme quinone reductase in Hepalclc7 cells
48. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol